Elevations in GFAP, NF-L, and PRDX-6 point to a cycle of BBB disruption, axonal injury, oxidative stress, and neuroinflammation—factors that are closely linked to cognitive decline and neurodegenerative diseases [131,132]. Here, GFAP is linked to neurodegenerative disease.